Quantitative Analysis of Pancreatic Polypeptide Cell Distribution in the Human Pancreas

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Wang, Xiaojun ^a,b   Zielinski, Mark C ^a   Misawa, Ryosuke ^a   Wen, Patrick ^a   Wang, Tian Yuan ^a   Wang, Cheng Zhang ^a   Witkowski, Piotr ^a   Hara, Manami ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PANCREAS POLYPEPTIDE;

ADULT; AGED; ARTICLE; CELL SHAPE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLUSTER ANALYSIS; ENDOCRINE CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PEPTIDE ANALYSIS; QUANTITATIVE ANALYSIS; STEREOLOGY; TISSUE SECTION;

GLUCAGON-SECRETING CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; PANCREAS; PANCREATIC POLYPEPTIDE-SECRETING CELLS;

EID: 84873180250     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055501     Document Type: Article

References (36)

1. Greenberg GR, McCloy RF, Adrian TE, Chadwick VS, Baron JH, et al. (1978) Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet 2: 1280-1282.
2. Lin TM, Evans DC, Chance RE, Spray GF, (1977) Bovine pancreatic peptide: action on gastric and pancreatic secretion in dogs. Am J Physiol 232: E311-E315.
3. Adrian TE, Mitchenere P, Sagor G, Bloom SR, (1982) Effect of pancreatic polypeptide on gallbladder pressure and hepatic bile secretion. Am J Physiol 243: G204-G207.
4. Hazelwood RL, (1993) The pancreatic polypeptide (PP-fold) family: gastrointestinal, vascular, and feeding behavioral implications. Proc Soc Exp Biol Med 202: 44-63.
5. Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, et al. (2003) Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 124: 1325-1336.
6. Wierup N, Svensson H, Mulder H, Sundler F, (2002) The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept 15;107: 63-69.
7. Andralojc KM, Mercalli A, Nowak KW, Albarello L, Calcagno R, et al. (2009) Ghrelin-producing epsilon cells in the developing and adult human pancreas. Diabetologia. 2009 52: 486-493.
8. Ueberberg B, Unger N, Saeger W, Mann K, Petersenn S, (2009) Expression of ghrelin and its receptor in human tissues. Horm Metab Res 41: 814-821.
9. Hasselby JP, Maroun LL, Federspiel BH, Vainer B, (2012) Ghrelin in the fetal pancreas- a digital quantitation study. APMIS 120: 157-166.
10. Vignjević S, Todorović V, Damjanović S, Budeč M, Mitrović O, et al. (2012) Similar developmental patterns of ghrelin- and glucagon-expressing cells in the human pancreas. Cells Tissues Organs 196: 362-373.
11. Orci L, Malaisse-Lagae F, Baetens D, Perrelet A, (1978) Pancreatic-polypeptide-rich regions in human pancreas. Lancet 2: 1200-1201.
12. Malaisse-Lagae F, Stefan Y, Cox J, Perrelet A, Orci L, (1979) Identification of a lobe in the adult human pancreas rich in pancreatic polypeptide. Diabetologia 17: 361-365.
13. Gersell DJ, Gingerich RL, Greider MH, (1979) Regional distribution and concentration of pancreatic polypeptide in the human and canine pancreas. Diabetes 28: 11-15.
14. Stefan Y, Orci L, Malaisse-Lagae F, Perrelet A, Patel Y, et al. (1982) Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 31: 694-700.
15. Rahier J, Wallon J, Loozen S, Lefevre A, Gepts W, et al. (1983) The pancreatic polypeptide cells in the human pancreas: the effects of age and diabetes. J Clin Endocrinol Metab 56: 441-444.
16. Kilimnik G, Kim A, Jo J, Miller K, Hara M, (2009) Quantification of pancreatic islet distribution in situ in mice. Am J Physiol Endocrinol Metab 297: E1331-E1338.
17. Miller K, Kim A, Klimnik G, Jo J, Moka U, et al. (2009) Islet formation during neonatal development. PLoS One 4: e7739.
18. Kim A, Kilimnik G, Guo C, Sung J, Jo J, et al. (2011) Computer-assisted large-scale visualization and quantification of pancreatic islet mass, size distribution and architecture. J Vis Exp49: pii:2471. doi: 10.3791/2471.
19. Kim A, Miller K, Jo J, Kilimnik G, Wojcik P, et al. (2009) Islet architecture - a comparative study. Islets 1: 129-136.
20. Kilimnik G, Zhao B, Jo J, Periwal V, Witkowski P, et al. (2011) Altered islet composition and disproportionate loss of large islets in patients with type 2 diabetes. PLoS One 6: e27445.
21. Kilimnik G, Jo J, Periwal V, Hara M, (2012) Quantification of islet distribution and architecture. Islets 4: 167-172.
22. Steiner DJ, Kim A, Miller K, Hara M, (2010) Pancreatic islet plasticity: interspecies comparison of islet architecture and composition. Islets 2: 135-145.
23. Jacobsson H, Larsson P, Jonsson C, Jussing E, Grybäck P, (2012) Normal uptake of 68Ga-DOTA-TOC by the pancreas uncinate process mimicking malignancy at somatostatin receptor PET. Clin Nucl Med 37: 362-365.
24. Chandra J, Grierson C, Bungay H (2012) Normal variations in pancreatic contour are associated with intestinal malrotation and can mimic neoplasm. Clin Radiol Jul 3. [Epub ahead of print].
25. Nathan H, Wolfgang CL, Edil BH, Choti MA, Herman JM, et al. (2009) Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective. J Surg Oncol 99: 87-92.
26. Sata N, Kurashina K, Nagai H, Nagakawa T, Ishikawa O, et al. (2009) The effect of adjuvant and neoadjuvant chemo(radio)therapy on survival in 1,679 resected pancreatic carcinoma cases in Japan: report of the national survey in the 34th annual meeting of Japanese Society of Pancreatic Surgery. J Hepatobiliary Pancreat Surg 16: 485-492.
27. Lau MK, Davila JA, Shaib YH, (2010) Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States. Pancreas 39: 458-462.
28. Bouvier AM, David M, Jooste V, Chauvenet M, Lepage C, et al. (2010) Rising incidence of pancreatic cancer in France. Pancreas 39: 1243-1246.
29. Bartosch-Härlid A, Andersson R, (2010) Diabetes mellitus in pancreatic cancer and the need for diagnosis of asymptomatic disease. Pancreatology 10: 423-428.
30. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R, (2009) Diabetes and cancer. Endocr Relat Cancer 16: 1103-1123.
31. Cui Y, Andersen D, (2012) Diabetes and pancreatic cancer. Endocr Relat Cancer 19: F9-F26.
32. Heitz PH, Polak JM, Bloom SR, Adrian TE, Pearse AGE, (1976) Cellular origin of human pancreatic polypeptide (HPP) in endocrine tumours of the pancreas. Virchows Arch B Cell Pathol 21: 259-265.
33. Schwartz TW, (1979) Pancreatic polypeptide (PP) and endocrine tumours of the pancreas. Scand J Gastroenterol 53: 93-100.
34. Floyd JC, Fajans SS, Pek S, Chance RE, (1976) A newly recognized pancreatic polypeptide: plasma levels in health and disease. Recent Prog Horm Res 33: 519-570.
35. Gepts W, De Mey J, Marichal-Pipeleers M, (1977) Hyperplasia of "pancreatic polypeptide" cells in the pancreas of juvenile diabetics. Diabetologia 13: 27-34.
36. Kahleova H, Mari A, Nofrate V, Matoulek M, Kazdova L, et al. (2012) Improvement in β-cell function after diet-induced weight loss is associated with decrease in pancreatic polypeptide in subjects with type 2 diabetes. J Diabetes Complications 26: 442-449.